Idrinol

Composition: Meldonium

Form: Solution for intravenous, intramuscular, and parabulbar injection

Indications: Ischemic heart disease, chronic heart failure, acute and chronic cerebral circulation disorders, physical and mental overstrain, withdrawal syndrome in chronic alcoholism, vascular pathologies of the fundus (hemophthalmia, central retinal vein thrombosis, branch occlusion, retinopathies).

Contraindications: Hypersensitivity, increased intracranial pressure, age under 18. Use with caution in liver and kidney diseases.

Dosage: IV, IM, or parabulbar. Usually 500–1000 mg daily for 10–14 days. In ischemia or stroke — up to 4–6 weeks. For overstrain — 10–14 days. Repeated courses — as prescribed by a physician.

Side effects: Rare — tachycardia, agitation, hypo- or hypertension, dyspepsia, itching, rash. Very rare — eosinophilia, weakness.

Interactions: Compatible with antianginal agents, anticoagulants, diuretics, bronchodilators. Enhances the effect of cardiac glycosides. Use with caution with nitrates, antihypertensives, and vasodilators.

Warnings: Use only in the first half of the day due to possible stimulating effect. Not a first-line drug for acute coronary syndrome. Not recommended during pregnancy and lactation.

Age restrictions: 18+

Pregnancy: Not recommended during pregnancy and lactation due to insufficient safety data.

Country of origin: Russia

Manufacturer: Sotex

Storage conditions: Store at temperatures not exceeding 25°C. Do not freeze. Keep out of reach of children.